Copy Link Print Information

Nicotinamide riboside malate

27 Cited Publications
Customer Review

Based on 27 publication(s) in Google Scholar

Nicotinamide riboside malate, an orally active NAD+ precursor, increases NAD+ levels and activates SIRT1 and SIRT3. Nicotinamide riboside malate is a source of vitamin B3 (niacin) and enhances oxidative metabolism, protection against high fat diet-induced metabolic abnormalities. Nicotinamide riboside malate reduces cognitive deterioration in a transgenic mouse model of Alzheimer’s disease.

For research use only. We do not sell to patients.

  • Purity: 98.04%
  • CAS No.: 2415659-01-5
  • Formula: C15H20N2O10
  • Molecular Weight:388.33
  • Storage:

    4°C, sealed storage, away from moisture

    * In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)

  • Nicotinamide riboside malate Chemical Structure
    Nicotinamide riboside malate Chemical Structure
  • Experimental Validation Results for Nicotinamide riboside malate
  • Experimental Validation Results for Nicotinamide riboside malate
  • Experimental Validation Results for Nicotinamide riboside malate
  • Experimental Validation Results for Nicotinamide riboside malate
  • Experimental Validation Results for Nicotinamide riboside malate
  • Experimental Validation Results for Nicotinamide riboside malate
  • Experimental Validation Results for Nicotinamide riboside malate
  • Experimental Validation Results for Nicotinamide riboside malate
  • Experimental Validation Results for Nicotinamide riboside malate
  • Experimental Validation Results for Nicotinamide riboside malate
  • Experimental Validation Results for Nicotinamide riboside malate
  • Experimental Validation Results for Nicotinamide riboside malate
  • Experimental Validation Results for Nicotinamide riboside malate
  • Experimental Validation Results for Nicotinamide riboside malate
CAS No.: 2415659-01-5
Size
Price
Stock
Quantity
Amount: USD 0.00
Please select quantity
or
or

* Please select Quantity before adding items.

To place orders, for customer services and technical support, please contact: MedChemExpress USA

Tel: 609-228-6898 E-mail: [email protected] [email protected]

Data Download
Other Forms of Nicotinamide riboside malate:

To place orders, for customer services and technical support, please contact:

609-228-6898
[email protected] [email protected]
Find Your Local Distributor Your local distributor: Hycultec GmbHHycultec
  • Biological Activity
  • Chemical Information
  • Solvent & Solubility
  • Purity & Documentation
  • References
  • Help & FAQs
You May Still Need
Top Publications Citing

Use of MCE Products

Publications Citing Use of MedChemExpress (MCE) Nicotinamide riboside malate

More
Customer Validation & Images
Bio/Physico-chemical AssayHistological Imaging/StainingCell Imaging/StainingIn Vivo Efficacy StudyIHC2D/3D Cell Culture and DifferentiationCell Proliferation/Viability AssayIFWB
  • Cell Proliferation/Viability Assay
  • IF
  • WB
  • Histological Imaging/Staining
  • Cell Imaging/Staining
  • In Vivo Efficacy Study
  • Cell Proliferation/Viability Assay
  • WB
  • IHC
  • Cell Proliferation/Viability Assay
  • Cell Proliferation/Viability Assay
  • Bio/Physico-chemical Assay
  • 2D/3D Cell Culture and Differentiation
  • Bio/Physico-chemical Assay

All Sirtuin Isoforms

More

All Endogenous Metabolite Isoforms

More
Keywords
100 mg

Get Quote In-stock

Please select quantity
Amount: USD 0.00
Sign in to MedChemExpress Sign In
Register
Sign in to MedChemExpress
Register New Account

At least 6 characters

Personalize your experience, you are currently not signed in. For a better experience, please create an online profile, you can:

Obtain points redemption prizes
Check out faster
Add multiple shipping locations
View orders
Assay Types
  • Nicotinamide riboside malate Chemical Structure
    Nicotinamide riboside malate Chemical Structure
    1/16
  • 1/16

    Nicotinamide riboside malate purchased from MedChemExpress. Usage Cited in: Bone Res. 2025 Jan 26;13(1):18. [Abstract]

    Customer Validation
     Effect of SIRT3 agonist (Nicotinamide riboside chloride; 0-1600 μM) on the proliferation of MC3T3-E1 cells was determined by CCK-8 assay after 2 days of stimulation

  • 1/16

    Nicotinamide riboside malate purchased from MedChemExpress. Usage Cited in: Bone Res. 2025 Jan 26;13(1):18. [Abstract]

    Customer Validation
     IF staining of SIRT3, BNIP3, NIX and DRP1 expression in MC3T3-E1 cells treated with DEX and SIRT3 agonist (800 μm).

  • 1/16

    Nicotinamide riboside malate purchased from MedChemExpress. Usage Cited in: Bone Res. 2025 Jan 26;13(1):18. [Abstract]

    Customer Validation
     WB analysis of SIRT3, BNIP3, NIX, DRP1, MFN1 and MFN2 expression in MC3T3-E1 cells treated with DEX and SIRT3 agonist (800 μM).

  • 1/16

    Nicotinamide riboside malate purchased from MedChemExpress. Usage Cited in: Res Sq. 2025 Mar 31.

    Customer Validation
     Representative hematoxylin and eosin (H&E)-stained sections of small intestines were collected at the end of the experiment (NR:Nicotinamide riboside,400 mg/kg/day； po for 4 weeks) or vehicle (phosphate buffer; at the same dose and volume as NR) once a day after irradiation exposure in C57BL/6 mouse)

  • 1/16

    Nicotinamide riboside malate purchased from MedChemExpress. Usage Cited in: Res Sq. 2025 Mar 31.

    Customer Validation
     Immunofluorescence detection of Ki-67 and ZO-1 in IECs between groups with NR (Nicotinamide riboside; 0.5 mM; 24 h).

  • 1/16

    Nicotinamide riboside malate purchased from MedChemExpress. Usage Cited in: Res Sq. 2025 Mar 31.

    Customer Validation
     Morphology of the SI and colon (NR:Nicotinamide riboside,400 mg/kg/day； po for 4 weeks) or vehicle (phosphate buffer; at the same dose and volume as NR) once a day after irradiation exposure in C57BL/6 mouse)

  • 1/16

    Nicotinamide riboside malate purchased from MedChemExpress. Usage Cited in: Invest Ophthalmol Vis Sci. 2024 Jul 1;65(8):1. [Abstract]

    Customer Validation
     The effect of different concentrations of NR (Nicotinamide riboside chloride;200,400, 800, 1000 μM) on primary human trabecular meshwork cells' viability after 24 and 72 hours of treatment, was determined by using the CCK-8 assay

  • 1/16

    Nicotinamide riboside malate purchased from MedChemExpress. Usage Cited in: Toxicol Appl Pharmacol. 2024 Aug 9:117066. [Abstract]

    Customer Validation
     WB images of SIRT3, AcK68-MnSOD and AcK122-MnSOD expressions in DRG tissues. Quantification of SIRT3, AcK68-MnSOD and AcK122-MnSOD expressions normalized with β-actin expressions and the Saline+Saline treated samples was set to 1 (NR (Nicotinamide riboside chloride); PTX (4 mg/kg, i. p.) Group, PTX (4 mg/kg, i.p.) + NR (400 mg/kg, i.g.) Group, PTX (4 mg/kg, I.P.) + NR (400 mg/kg, i.g.) +3-TYP (50 mg/kg, i.p.) group, NR (400 mg/kg, i.p.) group, 3-TYP (50 mg/kg, i.p.) group in SIRT3 WT mice)

  • 1/16

    Nicotinamide riboside malate purchased from MedChemExpress. Usage Cited in: Toxicol Appl Pharmacol. 2024 Aug 9:117066. [Abstract]

    Customer Validation
     The representative images depicting the expression of AcK68-MnSOD in each group were utilized for immunohistochemical detection (NR (Nicotinamide riboside chloride); PTX (4 mg/kg, i. p.) Group, PTX (4 mg/kg, i.p.) + NR (400 mg/kg, i.g.) Group, PTX (4 mg/kg, I.P.) + NR (400 mg/kg, i.g.) +3-TYP (50 mg/kg, i.p.) group, NR(400 mg/kg, i.p.) group, 3-TYP (50 mg/kg, i.p.) group in SIRT3 WT mice)

  • 1/16

    Nicotinamide riboside malate purchased from MedChemExpress. Usage Cited in: Cells. 2023 Oct 2;12(19):2396. [Abstract]

    Customer Validation
     THP-1 cells were supplemented with 200 µM NR (Nicotinamide riboside chloride) for 4 h before treatment with CEES or HN2 in growth medium (“Ctrl”) for 30 min. The “0” refers to solvent control. After exposure, cells were incubated with fresh growth medium with or without 200 µM NR for 20 h, and cell viability was measured with alamarBlue assay

  • 1/16

    Nicotinamide riboside malate purchased from MedChemExpress. Usage Cited in: Commun Biol. 2023 Mar 2;6(1):235. [Abstract]

    Customer Validation
     The cells were pretreated with NR (0.5 µM) for 1 h followed by post-incubation with LPS (1 µg/mL) or H2O2 (100 µM) for 24 h, quantitative analysis of cell viability in each group after LPS stimulation and H2O2 stimulation.

  • 1/16

    Nicotinamide riboside malate purchased from MedChemExpress. Usage Cited in: Redox Biol. 2022 Nov:57:102507. [Abstract]

    Customer Validation
     MitoParaquat (0.1 μM, 30 min) abolished the inhibition of platelet aggregation by nicotinamide riboside (1 mM, 30 min) or olaparib (20 μM, 30 min) in resting platelets from LST patients.

  • 1/16

    Nicotinamide riboside malate purchased from MedChemExpress. Usage Cited in: Redox Biol. 2022 Nov:57:102507. [Abstract]

    Customer Validation
     MitoParaquat (0.1 μM, 30 min) did not interrupt the improvements in mitochondrial respiration induced by nicotinamide riboside (1 mM) or olaparib (20 μM) in resting platelets from LST patients.

  • 1/16

    Nicotinamide riboside malate purchased from MedChemExpress. Usage Cited in: Cell Biosci. 2021 Nov 10;11(1):192.

    Customer Validation
     Relative ATP, NAD+, NADH, and NAD+/NADH levels in NR (Nicotinamide ribosid, 100 mM, 24 h) treatment SY5Y cells.

  • Nicotinamide riboside malate